COT Meeting: 25th March 2025

Meeting Agenda

1.    Apologies for absence.

2.     Draft minutes and reserved minutes of the Tuesday 4^th February 2025 meeting TOX/MIN/2025/01.

3.    Matters arising.         

4.    COT Workshop Report- Gut Reactions: xenobiotics and the microbiome TOX/2025/10 (Reserved).            

5.   Working Group on Plant-based drinks- Draft Report TOX/2025/11 (Reserved).                                               

6.   Review of the safety of ashwagandha in food, drinks and food supplements TOX/2025/12 (Reserved).           

7.   Update from FSA Fellow and PhD student TOX/2025/13.

8.   Risk Assessment of T2 and HT2 mycotoxins in food TOX/2025/14.

9.  Marine Biotoxin risk ranking TOX/2025/15.

10.  Citrinin in the maternal diet- first draft statement TOX/2025/16.

11.  Update on the work of other FSA Scientific Advisory Committees - for information TOX/2025/17.

12.  Reflections from the Chair.

13.  Any other business.

Matters arising:

• JEG updates.
• Subgroups and working groups.
• Ways of working- technical documentation.      

Media discussed during the meeting

TOX/MIN/2025/01

Draft Minutes of the 4th February 2025 COT Meeting

TOX/2025/09

Ways of working- technical documentation

Science and Research Special Topics Report

Annex A - Discussion paper on novel formulations of supplement compounds designed to increase oral bioavailability

TOX/2025/10

(Reserved)

TOX/2025/11

(Reserved)

Annex A, Annex B (Reserved

TOX/2025/12

(Reserved)

TOX/2025/13

Update from FSA Fellow and PhD student

TOX/2025/14

(Coming soon)

TOX/2025/15

(Coming soon)

TOX/2025/16

First draft statement on the potential risk from Citrinin in the maternal diet

TOX/2025/16 Annex A

TOX/2025/16 Annex B

TOX/2025/17

Update on the work of other Scientific Advisory Committees- March 2025